COLLEEN MONAGHAN: Open Payments
NPI 1255192563 · EASTON, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,287 in 32 payments from 18 companies in 2025. Trend: 2023 $99 · 2024 $1,357 · 2025 $1,287
Long term medical supply or device loan: $682Food & beverage: $605
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 9 | $720 |
| Regeneron Healthcare Solutions, Inc. | 3 | $91 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $56 |
| Daiichi Sankyo Inc. | 2 | $49 |
| AstraZeneca Pharmaceuticals LP | 2 | $40 |
| Janssen Biotech, Inc. | 2 | $38 |
| Caris MPI, Inc. | 1 | $36 |
| Exelixis Inc. | 1 | $34 |
| Genmab U.S., Inc. | 1 | $33 |
| PharmaEssentia USA Corporation | 1 | $33 |
Products named: KISQALI, LIBTAYO, Enhertu, LYNOZYFIC, MI CANCER SEEK, CABOMETYX, Epkinly, BESREMI.
Industry payments across MD — which companies pay providers there.
